Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes

NCT05610332 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Gastric Cancer

Interventions

DRUG: Camrelizumab
DRUG: Albumin Taxol
DRUG: FLOT scheme

Sponsor

Fujian Medical University